Dexcom Inc. Stock
Dexcom Inc. Stock
Dexcom Inc. gained 1.240% today.
The stock is an absolute favorite of our community with 25 Buy predictions and no Sell predictions.
With a target price of 115 € there is a hugely positive potential of 83.88% for Dexcom Inc. compared to the current price of 62.54 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 1.240% | 0.660% | -7.649% | -29.864% | -44.141% | -47.862% | 75.822% |
| Zimmer Holdings | 0.060% | 1.153% | -3.605% | -15.464% | -12.236% | -22.302% | -25.105% |
| Dentsply Sirona Inc. | 1.410% | 7.175% | 3.933% | -27.691% | -25.264% | -53.927% | -46.774% |
| Teleflex Inc. | 0.930% | -1.818% | 0.935% | 9.645% | -2.703% | -32.919% | -28.358% |
Comments
DexCom, Inc. (NASDAQ: DXCM) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $90.00 price target on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Stifel Nicolaus from $90.00 to $100.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target lowered by analysts at BTIG Research from $156.00 to $120.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company’s
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
With $200, one can afford many lottery tickets, one of which could be a winner. However, the odds of winning meaningful money by playing the lottery are minuscule. Investing in the stock market
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels.
But the stock has been performing poorly this year amid